X0607 3 2026-05-04 0 0001124105 GYRE THERAPEUTICS, INC. GYRE 0001959160 Luo Ying false C/O GYRE THERAPEUTICS, INC. 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 true true Chief Executive Officer Common Stock 2575541 I By Spouse Stock Option (Right to Buy) 0.32 2028-06-07 Common Stock 475300 D Stock Option (Right to Buy) 0.93 2030-01-12 Common Stock 237650 D Stock Option (Right to Buy) 0.75 2030-10-31 Common Stock 3378763 D Stock Option (Right to Buy) 2 2030-12-17 Common Stock 199626 D Stock Option (Right to Buy) 2 2031-04-16 Common Stock 988624 D Stock Option (Right to Buy) 5.98 2034-11-12 Common Stock 235273 D Stock Option (Right to Buy) 0.75 2030-10-31 Common Stock 2262755 I By Spouse These options are vested in full. This option represents a right to purchase 235,273 shares of the Issuer's common stock, one quarter of which vested on November 13, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Exhibit 24 - Power of Attorney /s/ Thomas Eastling, as attorney-in-fact for Ying Luo 2026-05-07